Knowledge of hepatitis C screening and management by internal medicine residents: trends over 2 years by Shehab, Thomas M. et al.
Knowledge of Hepatitis C Screening and
Management by Internal Medicine Residents:
Trends Over 2 Years
Thomas M. Shehab, M.D., Seema Sonnad, Ph.D., Achamyeleh Gebremariam, M.S., and
Philip Schoenfeld, M.D., M.S.Ed, M.Sc.(Epi)
Division of Gastroenterology, Department of Internal Medicine, and Department of Surgery, University of
Michigan Health System; CHOICES (Consortium for Health Outcomes Innovation and Cost-Effectiveness
Studies), University of Michigan; and Center for Excellence in Health Services Research, VAMC, Ann Arbor,
Michigan
OBJECTIVES: Over 2 million people in the United States are
infected with hepatitis C, and there has been an explosion in
knowledge regarding this disease in the last decade. Internal
medicine residents must be able to identify patients at risk
for hepatitis C and institute appropriate diagnostic testing
and referral of these patients.
METHODS: A survey regarding hepatitis C risk factors and
the management of hepatitis C patients was administered on
three occasions over 15 months (time 0, 1 month, and 15
months) to members of a large university–based internal
medicine residency.
RESULTS: During the study period 59 residents completed
all three surveys. Less than half of the residents (39%) ask
patients about hepatitis C risk factors. Only 58% reported
that they would refer a hepatitis C antibody positive patient
with elevated liver enzymes to a subspecialist on the initial
survey. The residents who did not refer patients cited low
response rates, high side-effect profiles, and the high cost of
therapy as reasons for not referring the patient. There was
significant improvement (58%vs 78%,p  0.01) in the rate
of patient referral during the 15-month study period but no
substantial improvement in the other knowledge deficits.
CONCLUSIONS: The knowledge base of the internal medi-
cine residents about hepatitis C screening and management
is suboptimal. New, more effective hepatitis C education
programs for internal medicine residents should be initiated.
(Am J Gastroenterol 2002;97:1216–1222. © 2002 by Am.
Coll. of Gastroenterology)
INTRODUCTION
Data from large scale epidemiological studies suggest that
approximately 1.8% of the United States population is pos-
itive for hepatitis C antibodies (1). During the last decade
there has been an explosion of knowledge regarding the
diagnosis, management, and natural history of hepatitis C.
In an effort to assimilate the information regarding this
disease, the National Institutes of Health (NIH) sponsored a
consensus conference on hepatitis C in March, 1997 (2). The
conference culminated in the NIH Consensus Statement on
Hepatitis C, a reference for physicians, patients, and the
general public. However, knowledge about screening and
management of hepatitis C may be insufficient among many
physicians.
Before the NIH consensus conference, primary care phy-
sicians demonstrated multiple deficiencies in their knowl-
edge about screening for and managing hepatitis C (3, 4).
Primary care physicians overestimated the importance of
certain risk factors (e.g., blood transfusion in 1994, casual
household contact), demonstrated significant confusion over
hepatitis C–specific diagnostic testing, and underreferred
patients to subspecialists (3). For example, 38% of primary
care physicians reported that they would not refer a hepatitis
C antibody positive patient with elevated transaminases to a
subspecialist (3). The knowledge deficits seen in this sur-
vey-based study likely translate into suboptimal patient
identification, excess laboratory-related expenditures, and
underreferral for ever improving hepatitis C therapy.
Given that internal medicine residents represent the next
generation of practicing internists, it is imperative that they
are able to identify patients at risk for hepatitis C, institute
appropriate initial diagnostic testing, and make appropriate
referrals. However, no previous study has evaluated poten-
tial deficiencies in internal medicine residents’ hepatitis C
knowledge.
Previous research on residents’ knowledge in other dis-
eases has demonstrated knowledge deficits and suboptimal
compliance with screening recommendations for breast can-
cer, colon cancer, and cervical cancer (5–9). In addition,
previous research has demonstrated knowledge deficits in
internal medicine residents regarding numerous diseases,
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specifically relating to laboratory utilization (10) and patient
management (11, 12). It is important to determine if similar
deficits exist in relation to the care of patients with hepatitis C.
We designed this study to determine 1) the baseline
knowledge of internal medicine residents regarding the di-
agnosis and management of HCV infection, 2) the effec-
tiveness of passive dissemination of the NIH consensus
statement as an educational tool for medicine residents, and
3) the change in the knowledge base of a cohort of internal
medicine residents during the course of their internal med-
icine residency (i.e., between 1997 and 1998). Identification
of knowledge gaps in the screening and management of
hepatitis C also may facilitate the development of specific
educational interventions to overcome these knowledge
gaps.
MATERIALS AND METHODS
Survey Design and Content
We developed a survey to assess physicians’ knowledge of
the risk factors and management of patients with hepatitis C.
The survey was initially developed after an evidence-based
review of the relevant literature. The survey was then pre-
sented to a focus group of clinical hepatologists and a focus
group of gastroenterology fellows to assess content validity.
The focus groups provided written and verbal feedback on
the survey and it was revised. The survey was then piloted
among a cohort of primary care physicians to evaluate the
clarity of survey questions and revised a second time (3).
The revised survey contained seven questions on risk
factors and 10 questions on the management of patients with
hepatitis C. A copy of this survey can be obtained from the
authors. The questions on risk factors listed various expo-
sures (e.g., i.v. drug use [IVDU], blood transfusion in 1982,
multiple sexual partners, monogamous sexual contact), and
the respondents were asked to rate each of the exposures as
a “significant” or “minimal” risk factor for HCV infection
(Fig. 1). Patient management questions were based on two




● elevated ALT (150 U/L) during checkup for life insurance
● subsequent workup: anti-HCV (ELISA)
● otherwise healthy/asymptomatic
● history of IVDU in 1963
Vignette 2
32-yr-old woman
● anti-HCV (ELISA) at blood donation
● subsequent workup: normal ALT
● healthy/asymptomatic
● no risk factors
The vignette-based questions focused on physicians’ deci-
sions to refer patients, HCV testing, and attitudes toward
biopsy and therapy. Based on available data, IVDU and
blood transfusion in 1982 are considered to be significant
HCV risk factors, whereas casual household contact and
blood transfusion in 1994 are not. In addition, based on the
Figure 1. Percentages of respondents answering that various exposures were significant risks for acquiring hepatitis C.
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NIH consensus statement, the patient in vignette 1 is a
patient who should 1) undergo testing to confirm viremia, 2)
undergo liver biopsy, and 3) be evaluated by a subspecialist
to be considered for therapy.
The survey also elicited demographic information on the
respondents, including year of training, number of HCV
patients seen in the previous year, experience with inter-
feron therapy, and experience on the gastroenterology ser-
vice. The 1998 survey contained additional questions asking
respondents about utilization of educational tools to learn
about hepatitis C.
Survey Administration
The survey was placed in the mailbox of members of the
1st- and 2nd-yr internal medicine residents at the University
of Michigan in March, 1997 (referred to as “1997 pre”
group throughout). We included a cover letter explaining the
purpose of the survey. The cover letter also stated that the
results of individual surveys would not be shared with the
residency administration. A postcard with the resident’s
“study” number was stapled to each survey, and when the
survey was received the postcard was removed. We were
therefore able to track who completed each survey but could
not track the performance of an individual resident over
time.
The NIH consensus statement was distributed to each
resident’s mailbox 2 wk after the survey. We again distrib-
uted copies of the survey 2 wk after distributing the NIH
statement (“1997 post” group). Fifteen months after the
original mailing (June, 1998) the group received the survey
for the third time (“1998” group).
Internal Medicine Residency Population Exposure to
Education About Hepatitis C
The residency surveyed is a large university–based resi-
dency with residents rotating at the tertiary care university
hospital and a large Veteran’s Administration hospital. The
residents also have a half-day per week general medicine
continuity of care clinic. The residency has a 1-hr lunchtime
lecture series 4 days each week that cycles over a 24-month
period. During the cycle there is one lecture on hepatitis C
and an overview lecture on viral hepatitis (includes infor-
mation on hepatitis C). Each of these lectures occurred
during the study period. The residents also attend Grand
Rounds 1 hr each week, and during the study period there
was one Grand Rounds session that focused on hepatitis C;
the lecture was an overview of hepatitis C and an update on
new developments. When on ambulatory rotations (3–5
months each year), the residents have a 1-hr ambulatory
conference each day, and hepatitis C is discussed during
ambulatory conferences 1–2 times each year. Most residents
spend at least 2 wk in the outpatient gastroenterology/
hepatology clinic during their residency, and all residents
spend 1–2 months on the inpatient gastroenterology/hepa-
tology service during their residency.
Statistical Analysis
The responses of the 1997 pre and 1997 post as well as the
1997 pre and 1998 surveys were compared by Student’s t
tests for continuous data and 2 tests for association for
noncontinuous data. To identify factors that influence resi-
dents’ responses, the responses to each question were ana-
lyzed based on year of training and the number of patients
seen in the last year. A sample size of 50 residents is
adequate to identify a 25% change in the proportion of
residents who would refer the patient in vignette 1 to a
gastroenterologist, assuming an SD of 6% and given that
  0.05 and power  0.80.
RESULTS
Demographic Data
Fifty-nine residents completed all three surveys. Eleven
residents (16% of all eligible residents) did not complete all
surveys and were not analyzed. A majority of the respon-
dents were male (64%) (Table 1). The respondents to the
1997 survey were nearly evenly distributed between the 1st-
and 2nd-yr classes of the residency. When the 1997 pre and
the 1998 cohorts of respondents were compared, there were
significantly more residents who had done GI rotations (p 
0.01) in the 1998 group. During the 1997 presurvey and the
1997 postsurvey, the majority of internal medicine residents
stated that they had cared for 1–5 patients with hepatitis C
in the past year. However, when the 1997 and 1998 surveys
were compared, the respondents in 1998 were more likely to
have seen more HCV patients in the last year (p  0.01).
At the time of the initial survey (1997 pre) only 4% of the
residents had seen the NIH consensus statement, whereas
75% stated that they had seen it at the time of the 1997
postintervention survey (p  0.00001) (Table 1). In the
1998 survey, 5% of the residents had not used any educa-
tional tools in the last 2 yr to learn about hepatitis C,
whereas 67% had used two or more tools. When asked to list
all educational tools they had used, 62% reported using
journal/review articles to learn about hepatitis C, whereas
61% reported learning from Grand Rounds/noon confer-
ences and 18% used online sites.
HCV Screening and Risk Factor Assessment in the 1997
Postintervention Cohort
There were no statistically significant differences between
the 1997 pre and the 1997 postintervention groups with
regard to risk factor knowledge or patient management (Fig.
1 and Table 3). There was a trend for all risk factors to be
considered significant more often, but the differences did
not reach statistical significance. In addition, when compar-
ing the 1997 pre and post surveys, there was a trend toward
increased rates of referral, biopsy, and treatment for the
patient in vignette 1.
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HCV Screening and Risk Factor Assessment in the 1998
Cohort
In the 1998 cohort, less than half of the residents (39%)
reported asking all of their patients about hepatitis C risk
factors (Table 2). Only 29% would test all patients with
HCV risk factors for hepatitis C, and only 32% would test
all patients with elevated liver enzymes for hepatitis C.
The residents were asked to rate various exposures as
“significant” or “minimal” risks for acquiring hepatitis C.
The majority identified IVDU and blood transfusion in 1982
as significant risk factors in all surveys (Fig. 1). When the
1997 preintervention results were compared with the 1998
results, the 1998 cohort was significantly more likely to
answer that multiple sexual contacts (75% vs 92%, p 
0.05) and casual household contact (2% vs 10%, p  0.05)
were significant risk factors. There was a trend toward all
the risk factors being considered significant more fre-
quently.
Patient Management
In the 1997 preintervention survey, a majority of the resi-
dents (58%) reported that they would refer the patient in
vignette 1 to a gastroenterologist (Table 3). The 42% that
would not refer the patient to gastroenterology cited low
response rates, high side effect profiles, and high medication
cost as reasons for not referring the patient. The majority
would support liver biopsy (75%) and therapy (67%) in the
patient in vignette 1, if recommended by a gastroenterolo-
gist. When asked which tests they would order for the
patient in vignette 1, 36% said they would repeat the
anti-HCV (ELISA), 66% would order anti-HCV (RIBA),
and 35% would order polymerase chain reaction. In man-
aging the patient in vignette 2, the 1997 cohort rarely
would refer the patient to a gastroenterologist (16%) and
would support biopsy (32%) and therapy (27%) approx-
imately a third of the time.
When the 1997 preintervention cohort and the 1998 co-
hort were compared, the 1998 cohort was significantly more
likely to refer the patient in vignette 1 to a gastroenterologist
(58% vs 78%, p  0.01) and to support therapy (67% vs
81%, p  0.05). The 1998 cohort was also significantly








Male 64% 64% 64%
Female 36% 36% 36%
Age 28 yr 28 yr 29 yr
Year of training
1 56% 56% 0%
2 44% 44% 56%
3 0% 0% 44%
Have you done a
gastroenterology rotation
Yes 58% 63% 95%
Number of outpatients with
hepatitis C cared for in
last year
0 patients 46% 43% 30%
1–5 patients 49% 52% 59%
6–10 patients 4% 4% 8%
10 patients 1% 1% 3%
Have you seen the NIH
consensus statement?
Yes 4% 75% NA
Did you complete this
survey previously?
Yes NA 100% 100%
NA  not applicable.





Do you ask all patients about HCV risk
factors?
39
Do you test patients for HCV
infection?
45
Which of the following patients do
you test?
All patients with elevated liver
enzymes?
32
All patients with elevated enzymes
and HCV risk factors?
51
All patients with elevated enzymes
and no identifiable cause?
50
All patients with HCV risk factors
regardless of cause?
29
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more likely to refer the patient in vignette 2 to a gastroen-
terologist (16% vs 30%, p  0.02).
Treatment Recommendations
The 1998 cohort was asked to select among therapeutic
regimens for the patient in vignette 1 (Table 3). Twenty-nine
percent would recommend interferon monotherapy, 60%
would recommend combination therapy with interferon and
ribavirin, and 11% answered that they did not know which
regimen they would order.
Of residents that chose combination therapy as the treat-
ment of choice for the patient in vignette 1, 3% expected the
response rate to be approximately 75%, 88% expected the
response rate to be 25–50% and 7% did not know the
expected response rate.
DISCUSSION
Hepatitis C is a major health problem in the United States.
It is essential for internal medicine residents to recognize
patients at risk for this disease, institute proper diagnostic
evaluation, and perform initial management and proper re-
ferral of these patients. In this study we used a survey to
determine 1) the baseline knowledge of internal medicine
residents regarding the diagnosis and management of HCV
infection, 2) the effectiveness of passive dissemination of
the NIH consensus statement as an educational tool for
medicine residents, and 3) the change in the knowledge base
of a cohort of internal medicine residents between 1997 and
1998.
Hepatitis C is often clinically silent until the late stage of
Table 3. Management of Patients With Hepatitis C
Percentage of Respondents Replying Yes
1997 Pre 1997 Post 1998
Vignette 1
At this point your next step would be to
reassure the patient that he or she is immune to hepatitis C 0 0 0
observe patient in clinic; no referral 7 11 7
observe in clinic; refer if symptoms develop 35 27 13*
refer to a gastroenterologist 58 62 78*
Don’ t know 0 0 2
What tests would you do (check all that apply)?
Anti-HCV ELISA 36 40 24
Anti-HCV by RIBA 66 62 71
HCV RNA by polymerase chain reaction 35 38 51*
HCV genotyping 6 9 13
Would you support a liver biopsy if recommended by a gastroenterologist?
Yes 75 77 82
Would you support therapy if recommended by a gastroenterologist?
Yes 67 65 81*
If you support therapy, what regimen would you recommend?
Interferon for 6 mo NA NA 16
Interferon for 12 mo 13
Ribavirin alone 0
Interferon and ribavirin 60
Don’ t know 11
Vignette 2
At this point your next step would be to
reassure the patient that he or she is immune to hepatitis C 0 0 1
observe patient in clinic; no referral 38 36 36
observe in clinic; refer if symptoms develop 45 42 32
refer to a gastroenterologist 16 19 30*
Don’ t know 1 3 1
What tests would you do (check all that apply)?
Anti-HCV ELISA 57 55 50
Anti-HCV by RIBA 46 38 44
HCV RNA by polymerase chain reaction 42 41 59*
HCV genotyping 1 7† 8*
Would you support a liver biopsy if recommended by a gastroenterologist?
Yes 32 32 32
Would you support therapy if recommended by a gastroenterologist?
Yes 27 25 36
If you support therapy, what regimen would you recommend? NA NA NA
NA  not applicable.
* Denotes statistically significant difference between 1997 pre and 1998 responses (p  0.05).
† Denotes statistically significant difference between 1997 pre and 1997 post responses (p  0.05).
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the disease, and it is therefore important for physicians to be
able to identify patients at risk so that proper testing can be
instituted (13). Although current recommendations do not
advise screening the general population for hepatitis C using
laboratory tests, both the Centers for Disease Control and
the NIH consensus conference have recommended that all
patients be screened for hepatitis C risk factors (2, 14). This
study is the first to specifically assess internal medicine
residents’ attitudes and knowledge regarding screening and
testing for hepatitis C. Despite recommendations to ask all
patients about hepatitis C risk factors, more than half of the
residents reported that they do not do so. This may result in
significant underrecognition of patients with clinically silent
disease. It is clear from these data that hepatitis C–specific
teaching directed at residents must stress the importance of
inquiring about risk factors for hepatitis C and define the
spectrum of patients that warrants HCV testing.
To recognize patients at risk for hepatitis C, physicians
must have adequate knowledge of the risk factors for the
disease. The residents surveyed in this study were able to
assess the risk level for most exposures. Our study, how-
ever, did not assess the actual rates of asking about specific
risk factors or the manner in which they inquired about risk
factors. Previous research has demonstrated that patients are
often evasive about answering questions regarding subjects
such as IVDU, multiple sexual partners, and cocaine use
(15).
The NIH consensus conference would say that the patient
in vignette 1 is a patient who should undergo further testing,
liver biopsy, and, likely, therapy (2). The respondents in this
study demonstrated considerable confusion in the ordering
of appropriate laboratory tests. Thirty-six percent of the
1997 respondents would needlessly repeat the HCV anti-
body test via ELISA, and 66% would order RIBA for the
patient in vignette 1. In this patient with risk factors and
elevated enzymes, the pretest probability that the original
anti-HCV (ELISA) is a “ true positive” is extremely high,
and therefore further antibody testing would be unnecessary
(14, 16, 17). Similar findings were seen in the 1998 survey,
and the confusion over additional testing may lead to ex-
cessive health care expenditures.
In 1997, only 58% of the residents said they would refer
the patient in vignette 1 to a gastroenterologist. Over the 15
months between the first and last surveys, the percentage of
residents referring the patient to a gastroenterologist and
supporting therapy increased significantly. However, even
in 1998, 22% would not refer this patient to a gastroenter-
ologist. Given that the current practice in the United States
is for subspecialists to administer hepatitis C therapy, these
data suggest that a significant proportion of hepatitis C
patients in the United States will not have access to treat-
ment.
Previously we assessed the knowledge regarding HCV
among primary care physicians (3). The first portion of the
current study was done within a month of the study of the
primary care physicians. The knowledge of internal medi-
cine residents was comparable to the knowledge of primary
care physicians in practice. The primary care physicians
studied were members of a large health maintenance orga-
nization owned by the university where the residents
trained. The similarity in knowledge between the two
groups may reflect the passage of knowledge and practice
patterns from the practicing physicians to the residents.
In this study we did not show an impact of the NIH
consensus statement as an educational tool. This study does
not prove that the statement is an ineffective educational
tool, given that the methodology of this study may have
limited the effectiveness in many ways. The methodological
limitations include 1) the consensus statement was placed in
the residents’ mailboxes with no supporting information, 2)
we did not identify from whom the consensus statement was
sent, and 3) we did not inform the residents that they would
be resurveyed about hepatitis C 1 month after receiving the
survey. In addition, we did not collect data regarding how
much, if any, of the NIH statement the residents read.
Previous research regarding the education of physicians and
physicians in training suggests that 13 pages of text placed
in a resident’s mailbox is a suboptimal educational tool
compared with interactive or even didactic learning sessions
(18–20).
The findings of this study demonstrate significant knowl-
edge deficits that likely translate into suboptimal patient
care. However, this study has several limitations. First, we
recognize that self-reported knowledge does not necessarily
translate into the care the physician provides. Second, this
study was performed at a single institution and may not
reflect the current level of knowledge nationally among
internal medicine residents. Finally, if a similar study is
done in the future it will be important to track the perfor-
mance of individual residents over time and to assess the
impact of more effective educational interventions on their
learning.
In summary, internal medicine residents’ knowledge re-
garding hepatitis C is suboptimal but similar to that of
practicing physicians in the same state. Acknowledging that
hepatitis C is only one of many diseases about which resi-
dents must learn, specific educational tools are needed to
optimize their knowledge of this disease. The availability of
easily accessible, easy-to-use hepatitis C–specific guidelines
may help residents in the initial management of hepatitis C
patients. Also, standardized patient questionnaires that con-
tain sensitive and specific questions regarding risk factors
for hepatitis C may optimize patient identification. Finally,
hepatitis C–specific educational interventions should be in-
teractive and case based rather than classic didactic lectures.
In the future, education of internal medicine residents re-
garding hepatitis C should focus on recognition of asymp-
tomatic patients and proper initial evaluation and testing. In
addition, an effort must be made to increase the frequency
of residents inquiring about hepatitis C risk factors to opti-
mize patient identification.
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